Shares of Aemetis, Inc. (NASDAQ:AMTX – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $4.33 and traded as low as $3.60. Aemetis shares last traded at $3.63, with a volume of 716,903 shares traded.
Analysts Set New Price Targets
Several brokerages have weighed in on AMTX. Stifel Nicolaus lowered their target price on Aemetis from $8.00 to $6.50 and set a “buy” rating for the company in a report on Wednesday, February 21st. Truist Financial reduced their price target on Aemetis from $5.00 to $3.50 and set a “hold” rating for the company in a research report on Tuesday, January 23rd.
Get Our Latest Stock Analysis on AMTX
Aemetis Price Performance
Aemetis (NASDAQ:AMTX – Get Free Report) last announced its quarterly earnings data on Thursday, March 7th. The specialty chemicals company reported ($0.34) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. The firm had revenue of $70.76 million during the quarter, compared to analyst estimates of $80.08 million. During the same period in the prior year, the company posted ($0.63) earnings per share. On average, research analysts predict that Aemetis, Inc. will post -1.6 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the company. Stifel Financial Corp boosted its stake in shares of Aemetis by 58.0% in the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock worth $2,870,000 after buying an additional 253,745 shares during the last quarter. Citigroup Inc. boosted its stake in shares of Aemetis by 10,391.3% in the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock worth $311,000 after buying an additional 74,298 shares during the last quarter. Sonora Investment Management Group LLC purchased a new stake in shares of Aemetis in the third quarter worth about $166,000. Finally, Barclays PLC purchased a new stake in shares of Aemetis in the third quarter worth about $150,000. 27.02% of the stock is owned by institutional investors and hedge funds.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
See Also
- Five stocks we like better than Aemetis
- Stock Market Upgrades: What Are They?
- High-Yield Texas Instruments Could Hit New Highs Soon
- High Flyers: 3 Natural Gas Stocks for March 2022
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Read Stock Charts for Beginners
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.